This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Equity Remove Thousand Oaks Remove Venture Capital Related Topics
Capital Develop Funding Technology Startup UCLA Research Development Companies Company More Related Topics >
article thumbnail

ImmunGene Raises $9M

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. immungene venture capital biotech biotechnology cancer therapeutics' READ MORE>>.

Thousand Oaks 164
Thousand Oaks UCLA Venture Capital Equity 164
article thumbnail

Amgen Backs Therapeutic Antibody Firm

socalTECH

SEPTEMBER 8, 2011

Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. According to Seattle-based Theraclone Sciences , Amgen Ventures was one of the investors in a $10.6M, Series B extension round for the company. READ MORE>>.

Thousand Oaks 150
Thousand Oaks Venture Capital Equity Capital 150
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 5,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024